Skip to main content
. 2006 Jun;55(6):809–814. doi: 10.1136/gut.2005.084574

Table 3 Results of single locus analyses at OCTN1, OCTN2, and IGR2096C>A for 1104 inflammatory bowel disease (IBD) cases and 750 controls.

Gene (variant) Risk allele frequency (n (%)) ORIBD (95% CI) Genotype (n (%)) ORIBD (95% CI) PIBD (for association assuming multiplicative model)
IBD UC CD Controls IBD UC CD Controls
OCTN1 1027 473 471 616 1.31 CC 284 (26.2) 131 (26.3) 124 (25.3) 261 (34.7) 1.00 (ref) 0.00010
+1672 (47.3) (47.4) (48.0) (41.0) (1.14–1.50) CT 575 (53.0) 263 (52.7) 263 (53.6) 366 (48.7) 1.44 (1.17–1.79)
TT 226 (20.8) 105 (21.0) 104 (21.2) 125 (16.6) 1.66 (1.26–2.19)
OCTN2 1124 526 510 695 1.31 GG 219 (20.5) 98 (19.7) 97 (20.1) 211 (28.1) 1.00 (ref) 0.00014
−207 (52.5) (52.9) (52.8) (46.3) (1.14–1.50) GC 580 (54.2) 272 (54.7) 262 (54.2) 385 (51.3) 1.45 (1.15–1.82)
CC 272 (25.4) 127 (25.6) 124 (25.7) 155 (20.6) 1.69 [1.29–2.22)
IGR2230 1155 543 518 693 1.31 CC 229 (20.8) 99 (19.4) 105 (21.3) 209 (27.8) 1.00 (ref) 0.00008
(52.6) (53.2) (52.4) (46.1) (1.15–1.51) CT 585 (53.2) 279 (54.7) 260 (52.6) 391 (52.1) 1.37 (1.09–1.71)
TT 285 (25.9) 132 (25.9) 129 (26.1) 151 (20.1) 1.73 (1.31–2.26)
IGR2096 1023 471 465 609 1.29 CC 288 (26.4) 137 (27.2) 124 (25.2) 255 (34.4) 1.00 (ref) 0.00010
(47.0) (42.7) (47.4) (41.1) (1.11–1.48) CT 579 (53.2) 259 (51.6) 269 (54.8) 363 (49.0) 1.41 (1.14–1.75)
TT 222 (20.4) 107 (21.2) 98 (20.0) 123 (16.6) 1.61 (1.22–2.12)
IGR3096 1106 591 495 655 1.30 TT 250 (22.9) 109 (21.5) 116 (23.6) 224 (30.1) 1.00 (ref) 0.00010
IGR3096 (50.6) (51.3) (50.4) (44.0) (1.14–1.49) TC 580 (53.1) 275 (54.3) 255 (51.9) 385 (51.7) 1.34 (1.08–1.68)
CC 263 (24.1) 122 (24.1) 120 (24.4) 135 (18.1) 1.74 (1.32–2.29)

Genotype and allele frequencies are also given for the 496 individuals with Crohn's disease (CD) and the 512 individuals with ulcerative colitis (UC). Smoking and sex are included as confounders.